| Corey Michelle Branstetter, APRN | |
|
407 Virginia Dr, Batesville, AR 72501-7329 | |
| (870) 793-4200 | |
| Not Available |
| Full Name | Corey Michelle Branstetter |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 407 Virginia Dr, Batesville, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417562224 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 212978 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| White River Medical Center | Batesville, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cardiology Associates Of Jonesboro, Inc | 8224218425 | 37 |
| St Bernards Physician Clinics Inc | 7012311269 | 172 |
News Archive
Increased physical activity is now being emphasized as a treatment option for the gastric intestinal disease known as IBS. Research at Sahlgrenska Academy, Sweden, indicates improvements in both intestinal function and self-esteem of patients who exercise more.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has accepted for review the company's supplemental new drug application for COPAXONE (glatiramer acetate injection) 40mg/ 1mL, a higher concentration dose of COPAXONE that offers a less frequent three times a week dosing regimen administered subcutaneously for patients with relapsing-remitting multiple sclerosis.
Thermo Fisher Scientific Inc., the world leader in serving science, recently mobilized its Food Safety Response Center (FSRC) to develop a method to test for the presence of the veterinary drug phenylbutazone in horsemeat. Phenylbutazone, also known as "bute," is a potent painkiller banned in any horsemeat intended for human consumption.
Scientists have shown that a drug called NA-1 results in fewer brain lesions in patients who have undergone surgery to repair a brain aneurysm, compared to placebo, and appears to be safe to use, according to an Article published Online First in The Lancet Neurology.
› Verified 7 days ago
| Entity Name | Cardiology Associates Of Jonesboro, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649570425 PECOS PAC ID: 8224218425 Enrollment ID: O20110204000602 |
News Archive
Increased physical activity is now being emphasized as a treatment option for the gastric intestinal disease known as IBS. Research at Sahlgrenska Academy, Sweden, indicates improvements in both intestinal function and self-esteem of patients who exercise more.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has accepted for review the company's supplemental new drug application for COPAXONE (glatiramer acetate injection) 40mg/ 1mL, a higher concentration dose of COPAXONE that offers a less frequent three times a week dosing regimen administered subcutaneously for patients with relapsing-remitting multiple sclerosis.
Thermo Fisher Scientific Inc., the world leader in serving science, recently mobilized its Food Safety Response Center (FSRC) to develop a method to test for the presence of the veterinary drug phenylbutazone in horsemeat. Phenylbutazone, also known as "bute," is a potent painkiller banned in any horsemeat intended for human consumption.
Scientists have shown that a drug called NA-1 results in fewer brain lesions in patients who have undergone surgery to repair a brain aneurysm, compared to placebo, and appears to be safe to use, according to an Article published Online First in The Lancet Neurology.
› Verified 7 days ago
| Entity Name | Arrhythmia Associates Of Nea, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407949555 PECOS PAC ID: 9537340054 Enrollment ID: O20110216000816 |
News Archive
Increased physical activity is now being emphasized as a treatment option for the gastric intestinal disease known as IBS. Research at Sahlgrenska Academy, Sweden, indicates improvements in both intestinal function and self-esteem of patients who exercise more.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has accepted for review the company's supplemental new drug application for COPAXONE (glatiramer acetate injection) 40mg/ 1mL, a higher concentration dose of COPAXONE that offers a less frequent three times a week dosing regimen administered subcutaneously for patients with relapsing-remitting multiple sclerosis.
Thermo Fisher Scientific Inc., the world leader in serving science, recently mobilized its Food Safety Response Center (FSRC) to develop a method to test for the presence of the veterinary drug phenylbutazone in horsemeat. Phenylbutazone, also known as "bute," is a potent painkiller banned in any horsemeat intended for human consumption.
Scientists have shown that a drug called NA-1 results in fewer brain lesions in patients who have undergone surgery to repair a brain aneurysm, compared to placebo, and appears to be safe to use, according to an Article published Online First in The Lancet Neurology.
› Verified 7 days ago
| Entity Name | St Bernards Physician Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447923438 PECOS PAC ID: 7012311269 Enrollment ID: O20210810001875 |
News Archive
Increased physical activity is now being emphasized as a treatment option for the gastric intestinal disease known as IBS. Research at Sahlgrenska Academy, Sweden, indicates improvements in both intestinal function and self-esteem of patients who exercise more.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has accepted for review the company's supplemental new drug application for COPAXONE (glatiramer acetate injection) 40mg/ 1mL, a higher concentration dose of COPAXONE that offers a less frequent three times a week dosing regimen administered subcutaneously for patients with relapsing-remitting multiple sclerosis.
Thermo Fisher Scientific Inc., the world leader in serving science, recently mobilized its Food Safety Response Center (FSRC) to develop a method to test for the presence of the veterinary drug phenylbutazone in horsemeat. Phenylbutazone, also known as "bute," is a potent painkiller banned in any horsemeat intended for human consumption.
Scientists have shown that a drug called NA-1 results in fewer brain lesions in patients who have undergone surgery to repair a brain aneurysm, compared to placebo, and appears to be safe to use, according to an Article published Online First in The Lancet Neurology.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Corey Michelle Branstetter, APRN 15 Equity Ct, Batesville, AR 72501-6343 Ph: (870) 805-9379 | Corey Michelle Branstetter, APRN 407 Virginia Dr, Batesville, AR 72501-7329 Ph: (870) 793-4200 |
News Archive
Increased physical activity is now being emphasized as a treatment option for the gastric intestinal disease known as IBS. Research at Sahlgrenska Academy, Sweden, indicates improvements in both intestinal function and self-esteem of patients who exercise more.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has accepted for review the company's supplemental new drug application for COPAXONE (glatiramer acetate injection) 40mg/ 1mL, a higher concentration dose of COPAXONE that offers a less frequent three times a week dosing regimen administered subcutaneously for patients with relapsing-remitting multiple sclerosis.
Thermo Fisher Scientific Inc., the world leader in serving science, recently mobilized its Food Safety Response Center (FSRC) to develop a method to test for the presence of the veterinary drug phenylbutazone in horsemeat. Phenylbutazone, also known as "bute," is a potent painkiller banned in any horsemeat intended for human consumption.
Scientists have shown that a drug called NA-1 results in fewer brain lesions in patients who have undergone surgery to repair a brain aneurysm, compared to placebo, and appears to be safe to use, according to an Article published Online First in The Lancet Neurology.
› Verified 7 days ago
Mr. Leroy Maupin Jr., APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 407 Virginia Dr, Batesville, AR 72501 Phone: 870-793-4200 Fax: 870-698-1353 | |
Angela Burleson, MS, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1215 Sidney St Ste 202, Batesville, AR 72501 Phone: 870-262-2000 | |
Rachel Jeannette Johnson, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 905 20th St Ste B, Batesville, AR 72501 Phone: 870-569-4942 Fax: 870-569-4943 | |
Mrs. Michelle Lee Hagen, ACNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1710 Harrison St, Batesville, AR 72501 Phone: 870-262-1200 Fax: 870-262-6199 | |
Cynthia Elaine Jackson, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3443 Harrison St, Batesville, AR 72501 Phone: 870-698-1635 Fax: 870-612-3389 | |
Brandy M Moore, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 255 Virginia Dr, Batesville, AR 72501 Phone: 870-793-4300 | |
Robin Kerr, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1215 Sidney St Ste 300, Batesville, AR 72501 Phone: 870-793-1126 Fax: 870-793-1180 |